Previous close | 3,900.00 |
Open | 3,900.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 3,900.00 - 3,900.00 |
52-week range | 2,671.39 - 4,012.00 |
Volume | |
Avg. volume | 3 |
Market cap | 574.692B |
Beta (5Y monthly) | 0.69 |
PE ratio (TTM) | 32.57 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 36.03 (0.92%) |
Ex-dividend date | 08 May 2024 |
1y target est | N/A |
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
This acquisition is expected to enhance Boston Scientific's (BSX) market position and revenue streams in North America and Europe.
QIAGEN's (QGEN) latest QCI Interpret release improves the performance of high-throughput NGS labs.